CTLA-4, PD-1, LAG3, TIM3 and TIGIT display distinct vesicular distributions in murine T cells

被引：0
|
作者：
Lu, Jiahe [1 ,2 ]
Simonetti, Boris [1 ,3 ]
Veler, Alisa [1 ]
Cross, Stephen [1 ]
Ruan, Xiongtao [4 ]
Raj, Timsse [1 ]
Dowsey, Andrew [1 ]
Murphy, Robert F. [4 ]
Verkade, Paul [1 ]
Cullen, Pete [1 ]
Wuelfing, Christoph [1 ]
机构：
[1] Univ Bristol, Bristol, Avon, England
[2] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[3] Charles River Labs, Bristol, Avon, England
[4] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2024年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
1713 - P2.
引用
收藏
页码：1182 / 1182
页数：1
相关论文
共 50 条
  • [21] Immunohistochemical Expression of Immune Checkpoints; CTLA-4, LAG3, and TIM-3 in Cancer Cells and Tumor-infiltrating Lymphocytes (TILs) in Colorectal Carcinoma
    Abdelrahman, Doaa I.
    Elhasadi, Ibtesam
    Anbaig, Amal
    Bakry, Adel
    Mandour, Doaa
    Wasefy, Tamer
    Yehia, Ahmed M.
    Alorini, Mohammed
    Shalaby, Amany M.
    Yahia, Amar Ibrahim Omer
    Alabiad, Mohamed A.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2024, 32 (02) : 71 - 83
  • [22] PD-1 but not CTLA-4 Blockage Abrogates the Protective Effect of Regulatory T Cells in a Pregnancy Murine Model
    Wafula, Paul Ojiambo
    Teles, Ana
    Schumacher, Anne
    Pohl, Kerstin
    Yagita, Hideo
    Volk, Hans-Dieter
    Zenclussen, Ana Claudia
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2009, 62 (05) : 283 - 292
  • [23] CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms
    Chemnitz, JM
    Riley, JL
    Frauwirth, KA
    Braunstein, I
    Kobayashi, SV
    Linsley, PS
    Thompson, CB
    Parry, RV
    BLOOD, 2004, 104 (11) : 726A - 726A
  • [24] CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms
    Parry, RV
    Chemnitz, JM
    Frauwirth, KA
    Lanfranco, AR
    Braunstein, I
    Kobayashi, SV
    Linsley, PS
    Thompson, CB
    Riley, JL
    MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (21) : 9543 - 9553
  • [25] Expression of the immune checkpoint receptors PD-1, LAG3, and TIM3 in the immune context of stage II and III gastric cancer by using single and chromogenic multiplex immunohistochemistry
    Park, Yujun
    Seo, An Na
    Koh, Jiwon
    Nam, Soo Kyoung
    Kwak, Yoonjin
    Ahn, Sang-Hoon
    Park, Do Joong
    Kim, Hyung-Ho
    Lee, Hye Seung
    ONCOIMMUNOLOGY, 2021, 10 (01):
  • [26] Enhancing Cytotoxicity of Autologous T Cells in AML By Blockade of CTLA-4 and PD-1
    Boughan, Kirsten Marie
    Chen, Xiaohua
    Szabolcs, Paul
    BLOOD, 2016, 128 (22)
  • [27] Oligoclonal T cells transiently expand and express TIM3 and LAG3 following CD19 CAR t cell therapy.
    Petersen, Christopher Thomas
    Jagirdar, Neera
    Waller, Edmund K.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [28] The introduction of LAG-3 checkpoint blockade in melanoma: immunotherapy landscape beyond PD-1 and CTLA-4 inhibition
    Kreidieh, Firas Y.
    Tawbi, Hussein A.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [29] The introduction of LAG-3 checkpoint blockade in melanoma: immunotherapy landscape beyond PD-1 and CTLA-4 inhibition
    Kreidieh, Firas Y.
    Tawbi, Hussein A.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [30] DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer
    Varun Sasidharan Nair
    Haytham El Salhat
    Rowaida Z. Taha
    Anne John
    Bassam R. Ali
    Eyad Elkord
    Clinical Epigenetics, 2018, 10
12345